Drug Profile


Alternative Names: Flavone acetic acid; LM 975; NSC 347512

Latest Information Update: 12 Mar 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Merck Sante
  • Class Cytostatics
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Cancer

Most Recent Events

  • 11 Apr 1995 Suspended-Phase-Unspecified for Cancer in Germany (IV)
  • 31 Mar 1995 A clinical study has been added to the therapeutic trials and adverse events sections
  • 08 Mar 1995 A clinical study has been added to the therapeutic trials, immunogenicity and adverse events sections
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top